Fig. 7.
Fig. 7. Effect of NK cell depletion on IL-18/IL-2 lethality. / (A) Effect of antiasialo-GM1 Ab. SCID mice (n = 5) were pretreated with 1 mg (100 μL) antiasialo-GM1 [asialo] Ab or control normal rabbit serum (NRS) on days 0 and 7 to deplete the NK-cell population. The NK-cell–depleted SCID mice were then treated daily with control PBS or IL-18 (1 μg) plus IL-2 (100 000 IU) once a day for 10 days. (B) Effect of anti-NK1.1 mAb. B6 mice (n = 5) were pretreated with 0.5 mg anti-NK1.1 mAb, CD4 mAb, CD8 mAb, or control antibody on days 0 and 7. Mice were then treated daily with IL-18 (1 μg) plus IL-2 (100 000 IU) once a day for 10 days.

Effect of NK cell depletion on IL-18/IL-2 lethality.

(A) Effect of antiasialo-GM1 Ab. SCID mice (n = 5) were pretreated with 1 mg (100 μL) antiasialo-GM1 [asialo] Ab or control normal rabbit serum (NRS) on days 0 and 7 to deplete the NK-cell population. The NK-cell–depleted SCID mice were then treated daily with control PBS or IL-18 (1 μg) plus IL-2 (100 000 IU) once a day for 10 days. (B) Effect of anti-NK1.1 mAb. B6 mice (n = 5) were pretreated with 0.5 mg anti-NK1.1 mAb, CD4 mAb, CD8 mAb, or control antibody on days 0 and 7. Mice were then treated daily with IL-18 (1 μg) plus IL-2 (100 000 IU) once a day for 10 days.

Close Modal

or Create an Account

Close Modal
Close Modal